ODS Medical Inc. announces Sentry™ System prototype for real-time Raman spectroscopy receives Health Canada testing authorization

MONTREAL, Aug. 1, 2019 /CNW Telbec/ – ODS Medical Inc. is pleased to announce that the company has received Investigational Testing Authorization from Health Canada for its SentryTM System Prototype. With this authorization, ODS Medical will be able to launch a new clinical study in brain cancer surgeries at The Neuro (Montreal Neurological Institute and Hospital). The study is scheduled to start later this month. Dr. Kevin Petrecca, Chief of Neurosurgery at the McGill University Health Centre, and ODS Medical Inc. co-founder, is the study’s principal investigator…

http://www.newswire.ca/en/releases/archive/August2019/01/c6601.html